AAV-hAADC-2

AAV-hAADC-2 · Genzyme, a Sanofi company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AAV-hAADC-2, covering 2013-12-04 to 2013-12-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AAV-hAADC-2 in Subjects With Parkinson's Disease [Phase 1]